Answer
The most frequently reported adverse reactions to evinacumab are nasopharyngitis (13.7%), influenza-like illness (7.7%), dizziness (6.0%), back pain (5.1%) and nausea (5.1%).
Sources for this answer
- Evkeeza 150 mg/ml concentrate for solution for infusionUltragenyx UK · emc · SmPC §4.8 Undesirable effects · Version 4Document updated
Sources checked